Page 3 - Singular Genomics News Today

HOYA (OTCMKTS:HOCPY – Get Rating) and Singular Genomics Systems (NASDAQ:OMIC – Get Rating) are both computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations. Volatility & Risk HOYA has a beta of […]

Revvity (NYSE:RVTY – Get Rating) and Singular Genomics Systems (NASDAQ:OMIC – Get Rating) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, earnings, institutional ownership and dividends. Analyst Recommendations This is a breakdown of recent ratings and […]

Singular Genomics Systems (NASDAQ:OMIC – Get Rating) and Revvity (NYSE:RVTY – Get Rating) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and earnings. Valuation and Earnings This table compares Singular Genomics Systems and […]

Singular Genomics Systems, Inc. (NASDAQ:OMIC – Get Rating) insider Eli N. Glezer purchased 170,000 shares of the stock in a transaction on Wednesday, May 17th. The stock was acquired at an average price of $0.82 per share, with a total value of $139,400.00. Following the completion of the acquisition, the insider now directly owns 4,355,000 […]

Rapid Micro Biosystems (NASDAQ:RPID – Get Rating) and Singular Genomics Systems (NASDAQ:OMIC – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership. Analyst Recommendations This is a summary of […]

Tecan has partnered with Singular Genomics to use the turnkey MagicPrep™ NGS system to create sequencing-ready libraries for the G4™ Sequencing Platform. The agreement will bring together Tecan’s expertise in laboratory automation, genomics and bioinformatics with Singular Genomics sequencing technology to simplify life in the lab.

Conor McNamara, CFA, an equity research analyst with RBC Capital Markets, discusses Icahn’s proxy battle against Illumina, and the company’s strengths and challenges, with GEN Edge.

Operator: Greetings, and welcome to the Singular Genomics Systems, Incorporated Fourth Quarter 2022 Earnings Conference Call. Please note, this conference is being recorded.

New technologies, recognition, and the thrill of discovery propel the field’s largest public and private companies (plus eight up-and-comers).

Advances in Genome Biology and Technology delivers cutting-edge genomics news by day, holds beachside festivities (enlivened by Flo Rida’s “Low”) at night.